UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 16, 2011 11:00 A.M.

Form:	S-3
CIK: 0001425205 Company Name: Genesis Biopharma, Inc File Number: 333-175184